DYADIC INTERNATIONAL INC Increase (Decrease) in Accrued Liabilities
DYADIC INTERNATIONAL INC (DYAI) reported Increase (Decrease) in Accrued Liabilities of $602.51 thousand for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-12.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInAccruedLiabilities · last filed 2026-08-12
- DYADIC INTERNATIONAL INC increase (decrease) in accrued liabilities for the quarter ending 2026-06-30 was $503.82K, a 110.81% increase year-over-year.
- DYADIC INTERNATIONAL INC increase (decrease) in accrued liabilities for the quarter ending 2026-03-31 was $98.69K.
- DYADIC INTERNATIONAL INC increase (decrease) in accrued liabilities for the quarter ending 2025-12-31 was -$404.39K, a 408.60% decline year-over-year.
- DYADIC INTERNATIONAL INC increase (decrease) in accrued liabilities for the quarter ending 2025-09-30 was $442.51K.
- DYADIC INTERNATIONAL INC increase (decrease) in accrued liabilities for fiscal 2025 was $229.13K, a 9.31% decline from fiscal 2024.
- DYADIC INTERNATIONAL INC increase (decrease) in accrued liabilities for fiscal 2024 was $252.66K, a 43.13% decline from fiscal 2023.
- DYADIC INTERNATIONAL INC increase (decrease) in accrued liabilities for fiscal 2023 was $444.27K, a 80.95% increase from fiscal 2022.
- DYADIC INTERNATIONAL INC increase (decrease) in accrued liabilities for fiscal 2022 was $245.52K, a 11.69% increase from fiscal 2021.
| Period end | Increase (Decrease) in Accrued Liabilities 3 month | Increase (Decrease) in Accrued Liabilities 3 month as first filed | Increase (Decrease) in Accrued Liabilities 6 month | Increase (Decrease) in Accrued Liabilities 9 month | Increase (Decrease) in Accrued Liabilities 12 month |
|---|---|---|---|---|---|
| 2026-06-30 | $503.82K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-12 | $602.51K 10-Q · filed 2026-08-12 | $198.12K derived: sum of 3 quarters · filed 2026-08-12 | $640.63K derived: sum of 4 quarters · filed 2026-08-12 | |
| 2026-03-31 | $98.69K 10-Q · filed 2026-05-13 | -$305.70K derived: sum of 2 quarters · filed 2026-05-13 | $136.81K derived: sum of 3 quarters · filed 2026-05-13 | $375.80K derived: sum of 4 quarters · filed 2026-08-12 | |
| 2025-12-31 | -$404.39K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-25 | $38.12K derived: sum of 2 quarters · filed 2026-03-25 | $277.11K derived: sum of 3 quarters · filed 2026-08-12 | $229.13K 10-K · filed 2026-03-25 | |
| 2025-09-30 | $442.51K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-12 | $681.50K derived: sum of 2 quarters · filed 2026-08-12 | $633.52K 10-Q · filed 2025-11-12 | $764.56K derived: sum of 4 quarters · filed 2026-08-12 | |
| 2025-06-30 | $238.99K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-12 | $191.01K 10-Q · filed 2026-08-12 | $322.05K derived: sum of 3 quarters · filed 2026-08-12 | $290.87K derived: sum of 4 quarters · filed 2026-08-12 | |
| 2025-03-31 | -$47.98K 10-Q · filed 2026-05-13 | $83.06K derived: sum of 2 quarters · filed 2026-05-13 | $51.88K derived: sum of 3 quarters · filed 2026-05-13 | -$66.46K derived: sum of 4 quarters · filed 2026-05-13 | |
| 2024-12-31 | $131.04K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-25 | $99.86K derived: sum of 2 quarters · filed 2026-03-25 | -$18.48K derived: sum of 3 quarters · filed 2026-03-25 | $252.66K 10-K · filed 2026-03-25 | |
| 2024-09-30 | -$31.18K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-12 | -$149.52K derived: sum of 2 quarters · filed 2025-11-12 | $121.62K 10-Q · filed 2025-11-12 | $558.54K derived: sum of 4 quarters · filed 2025-11-12 | |
| 2024-06-30 | -$118.34K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-13 | $152.80K 10-Q · filed 2025-08-13 | $589.72K derived: sum of 3 quarters · filed 2025-08-13 | $300.48K derived: sum of 4 quarters · filed 2025-08-13 | |
| 2024-03-31 | $271.14K 10-Q · filed 2025-05-14 | $708.07K derived: sum of 2 quarters · filed 2025-05-14 | $418.83K derived: sum of 3 quarters · filed 2025-05-14 | $465.27K derived: sum of 4 quarters · filed 2025-05-14 | |
| 2023-12-31 | $436.92K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-26 | $147.68K derived: sum of 2 quarters · filed 2025-03-26 | $194.12K derived: sum of 3 quarters · filed 2025-03-26 | $444.27K 10-K · filed 2025-03-26 | |
| 2023-09-30 | -$289.24K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-12 | -$242.80K derived: sum of 2 quarters · filed 2024-11-12 | $7.35K 10-Q · filed 2024-11-12 | -$25.46K derived: sum of 4 quarters · filed 2024-11-12 | |
| 2023-06-30 | $46.44K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-13 | $296.59K 10-Q · filed 2024-08-13 | $263.78K derived: sum of 3 quarters · filed 2024-08-13 | $27.33K derived: sum of 4 quarters · filed 2024-08-13 | |
| 2023-03-31 | $250.15K 10-Q · filed 2024-05-14 | $217.34K derived: sum of 2 quarters · filed 2024-05-14 | -$19.11K derived: sum of 3 quarters · filed 2024-05-14 | $672.06K derived: sum of 4 quarters · filed 2024-05-14 | |
| 2022-12-31 | -$32.81K derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-28 | -$269.26K derived: sum of 2 quarters · filed 2024-03-28 | $421.92K derived: sum of 3 quarters · filed 2024-03-28 | $245.52K 10-K · filed 2024-03-28 | |
| 2022-09-30 | -$236.45K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-08 | $454.73K derived: sum of 2 quarters · filed 2023-11-08 | $278.33K 10-Q · filed 2023-11-08 | $145.44K derived: sum of 4 quarters · filed 2023-11-08 | |
| 2022-06-30 | $691.17K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-09 | $514.78K 10-Q · filed 2023-08-09 | $381.89K derived: sum of 3 quarters · filed 2023-08-09 | $630.06K derived: sum of 4 quarters · filed 2023-08-09 | |
| 2022-03-31 | -$176.40K 10-Q · filed 2023-05-10 | -$176.40M 10-Q · filed 2022-05-12 | -$309.29K derived: sum of 2 quarters · filed 2023-05-10 | -$61.12K derived: sum of 3 quarters · filed 2023-05-10 | $212.13M derived: sum of 4 quarters · filed 2023-05-10 |
| 2021-12-31 | -$132.89K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-29 | $115.28K derived: sum of 2 quarters · filed 2023-03-29 | $212.31M derived: sum of 3 quarters · filed 2023-03-29 | $219.82K 10-K · filed 2023-03-29 | |
| 2021-09-30 | $248.17K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-10 | $212.44M derived: sum of 2 quarters · filed 2022-11-10 | $352.71K 10-Q · filed 2022-11-10 | $221.84K derived: sum of 4 quarters · filed 2022-11-10 | |
| 2021-06-30 | $212.19M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-10 | $104.55K 10-Q · filed 2022-08-10 | -$26.33K derived: sum of 3 quarters · filed 2022-08-10 | $212.78K derived: sum of 4 quarters · filed 2022-08-10 | |
| 2021-03-31 | -$212.09M 10-Q · filed 2022-05-12 | -$212.09K 10-Q · filed 2021-05-13 | -$212.22M derived: sum of 2 quarters · filed 2022-05-12 | -$211.98M derived: sum of 3 quarters · filed 2022-05-12 | -$211.84M derived: sum of 4 quarters · filed 2022-05-12 |
| 2020-12-31 | -$130.88K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-29 | $108.24K derived: sum of 2 quarters · filed 2022-03-29 | $245.87K derived: sum of 3 quarters · filed 2022-03-29 | -$80.13K 10-K · filed 2022-03-29 | |
| 2020-09-30 | $239.11K derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-10 | $376.75K derived: sum of 2 quarters · filed 2021-11-10 | $50.74K 10-Q · filed 2021-11-10 | $146.60K derived: sum of 4 quarters · filed 2021-11-10 | |
| 2020-06-30 | $137.63K derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-12 | -$188.37K 10-Q · filed 2021-08-12 | -$92.51K derived: sum of 3 quarters · filed 2021-08-12 | -$18.43K derived: sum of 4 quarters · filed 2021-08-12 | |
| 2020-03-31 | -$326.00K 10-Q · filed 2021-05-13 | -$230.14K derived: sum of 2 quarters · filed 2021-05-13 | -$156.07K derived: sum of 3 quarters · filed 2021-05-13 | -$62.99K derived: sum of 4 quarters · filed 2021-05-13 | |
| 2019-12-31 | $95.86K derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-30 | $169.93K derived: sum of 2 quarters · filed 2021-03-30 | $263.00K derived: sum of 3 quarters · filed 2021-03-30 | $166.40K 10-K · filed 2021-03-30 | |
| 2019-09-30 | $74.08K derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-12 | $167.15K derived: sum of 2 quarters · filed 2020-11-12 | $70.54K 10-Q · filed 2020-11-12 | $229.54K derived: sum of 4 quarters · filed 2020-11-12 | |
| 2019-06-30 | $93.07K derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-13 | -$3.54K 10-Q · filed 2020-08-13 | $155.47K derived: sum of 3 quarters · filed 2020-08-13 | $203.59K derived: sum of 4 quarters · filed 2020-08-13 | |
| 2019-03-31 | -$96.61K 10-Q · filed 2020-05-14 | $62.40K derived: sum of 2 quarters · filed 2020-05-14 | $110.52K derived: sum of 3 quarters · filed 2020-05-14 | -$52.56K derived: sum of 4 quarters · filed 2020-05-14 | |
| 2018-12-31 | $159.00K derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-30 | $207.13K derived: sum of 2 quarters · filed 2020-03-30 | $44.05K derived: sum of 3 quarters · filed 2020-03-30 | $251.62K 10-K · filed 2020-03-30 | |
| 2018-09-30 | $48.13K derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-13 | -$114.96K derived: sum of 2 quarters · filed 2019-11-13 | $92.62K 10-Q · filed 2019-11-13 | ||
| 2018-06-30 | -$163.08K derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-13 | $44.49K 10-Q · filed 2019-08-13 | |||
| 2018-03-31 | $207.57K 10-Q · filed 2019-05-09 | ||||
| 2017-12-31 | -$242.20K 10-K · filed 2019-03-27 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| BioCardia, Inc. (BCDA) | United States | $0.016B | |
| Passage BIO, Inc. (PASG) | United States | $0.015B | -0.43 |
| Pluri Inc. (PLUR) | $0.014B | ||
| INTENSITY THERAPEUTICS, INC. (INTS) | United States | $0.013B | -1.08 |
| BRAINSTORM CELL THERAPEUTICS INC. (BCLI) | United States | $0.013B | -1.05 |
| Jasper Therapeutics, Inc. (JSPR) | United States | $0.020B | -0.37 |
| IN8BIO, INC. (INAB) | United States | $0.012B | -0.76 |
| Estrella Immunopharma, Inc. (ESLA) | United States | $0.020B | |
| Senti Biosciences Holdings, Inc. (SNTI) | United States | $0.011B | -0.70 |
| TScan Therapeutics, Inc. (TCRX) | United States | $0.008B | -1.23 |